肺癌的凝血异常:诊断挑战和治疗前景
Athena Myrou1, Athanasios Penopoulos1, Konstantinos Barmpagiannos1
1Department of Internal Medicine, AHEPA University General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
概括
肺癌通常会导致血液凝固问题,导致血块或出血. 了解这些复杂的凝血问题是改善患者治疗结果和治疗的关键.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 血栓形成研究研究
背景情况:
- 肺癌经常出现凝血异常,包括静脉血栓塞栓症 (VTE) 和出血.
- 这种高凝血状态是由瘤因素,炎症,内皮功能障碍,自身免疫和治疗引起的.
- 这些问题影响了预后和治疗策略,抗脂抗体和获得的抑制剂增加了复杂性.
研究的目的:
- 为临床医生提供实用的见解,以管理肺癌中血栓性并发症.
- 审查肺癌患者凝血病的多方面的原因.
- 讨论癌症相关凝血病的新兴生物标志物和诊断/治疗方法.
主要方法:
- 关于肺癌相关凝血病的当前文献的综述.
- 讨论瘤生物学,全身影响和血液静止之间的相互作用.
- 探索新的生物标志物,诊断工具和管理策略.
主要成果:
- 肺癌相关的凝血病包括瘤前凝剂,炎症,内皮功能障碍和自身免疫因素.
- 细胞外囊泡,免疫媒介凝血病和免疫检查点抑制剂是越来越多的被认可的贡献者.
- 新型生物标志物 (例如,前体片段1+2,EV标志物) 显示出风险分层的前景.
- 诊断方法包括凝血试验,生物标志物分析和成像.
结论:
- 早期识别和针对癌症相关的凝血病的定制管理对于改善患者的治疗结果至关重要.
- 个性化抗凝剂和获得性抑制剂的管理是必不可少的.
- 对于患有出血或凝血风险的肺癌患者,需要对新生物标志物和治疗策略进行进一步的研究.
相关概念视频
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:29Pulmonary Embolism I: Introduction
45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45
01:27Pulmonary Embolism III: Nursing Management
38
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
38
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34